Literature DB >> 23339845

Lymphotoxin network pathways shape the tumor microenvironment.

Ryan L Bjordahl1, Christian Steidl, Randy D Gascoyne, Carl F Ware.   

Abstract

Accumulating evidence indicates that Lymphotoxin (LT)-β related cytokines directly contribute to the phenotype of cancer cells and alter the tumor microenvironment. Lymphotoxins are part of a cytokine network well known in controlling the development and homeostasis of secondary lymphoid organs. In the adult, the LT network takes on the responsibility of generating inflammatory microenvironments that control innate and adaptive immune responses involved in host defense. This review provides a perspective of the emerging evidence implicating the LT Network in the development and progression of various cancers including lymphoma. Redirecting the LT Network to alter tumor microenvironments may provide a specific approach to therapeutically target tumor-permissive microenvironments and cancer progression.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23339845      PMCID: PMC3646954          DOI: 10.1016/j.coi.2013.01.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  62 in total

Review 1.  Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines.

Authors:  P Hjelmström
Journal:  J Leukoc Biol       Date:  2001-03       Impact factor: 4.962

Review 2.  The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.

Authors:  Marcos W Steinberg; Timothy C Cheung; Carl F Ware
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

3.  Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway.

Authors:  Yukimi Sakoda; Jang-June Park; Yuming Zhao; Atsuo Kuramasu; Degui Geng; Yingjia Liu; Eduardo Davila; Koji Tamada
Journal:  Blood       Date:  2011-01-10       Impact factor: 22.113

Review 4.  Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response.

Authors:  Nancy H Ruddle; Eitan M Akirav
Journal:  J Immunol       Date:  2009-08-15       Impact factor: 5.422

Review 5.  Prognostic biomarkers in malignant lymphomas.

Authors:  Randy D Gascoyne; Andreas Rosenwald; Sibrand Poppema; Georg Lenz
Journal:  Leuk Lymphoma       Date:  2010-08

6.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

7.  A lymphotoxin-driven pathway to hepatocellular carcinoma.

Authors:  Johannes Haybaeck; Nicolas Zeller; Monika Julia Wolf; Achim Weber; Ulrich Wagner; Michael Odo Kurrer; Juliane Bremer; Giandomenica Iezzi; Rolf Graf; Pierre-Alain Clavien; Robert Thimme; Hubert Blum; Sergei A Nedospasov; Kurt Zatloukal; Muhammad Ramzan; Sandra Ciesek; Thomas Pietschmann; Patrice N Marche; Michael Karin; Manfred Kopf; Jeffrey L Browning; Adriano Aguzzi; Mathias Heikenwalder
Journal:  Cancer Cell       Date:  2009-10-06       Impact factor: 31.743

8.  BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.

Authors:  Laurent Derré; Jean-Paul Rivals; Camilla Jandus; Sonia Pastor; Donata Rimoldi; Pedro Romero; Olivier Michielin; Daniel Olive; Daniel E Speiser
Journal:  J Clin Invest       Date:  2009-12-28       Impact factor: 14.808

9.  Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses.

Authors:  Tangsheng Yi; Xiaoming Wang; Lisa M Kelly; Jinping An; Ying Xu; Andreas W Sailer; Jan-Ake Gustafsson; David W Russell; Jason G Cyster
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

10.  iNKT cells suppress the CD8+ T cell response to a murine Burkitt's-like B cell lymphoma.

Authors:  Ryan L Bjordahl; Laurent Gapin; Philippa Marrack; Yosef Refaeli
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

View more
  17 in total

Review 1.  Tumor necrosis factor superfamily in innate immunity and inflammation.

Authors:  John Šedý; Vasileios Bekiaris; Carl F Ware
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-18       Impact factor: 10.005

2.  TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses.

Authors:  Eleni Kotsiou; Jessica Okosun; Caroline Besley; Sameena Iqbal; Janet Matthews; Jude Fitzgibbon; John G Gribben; Jeffrey K Davies
Journal:  Blood       Date:  2016-04-21       Impact factor: 22.113

3.  Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.

Authors:  Michael Boice; Darin Salloum; Frederic Mourcin; Viraj Sanghvi; Rada Amin; Elisa Oricchio; Man Jiang; Anja Mottok; Nicolas Denis-Lagache; Giovanni Ciriello; Wayne Tam; Julie Teruya-Feldstein; Elisa de Stanchina; Wing C Chan; Sami N Malek; Daisuke Ennishi; Renier J Brentjens; Randy D Gascoyne; Michel Cogné; Karin Tarte; Hans-Guido Wendel
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

4.  Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.

Authors:  Rita Das; Jamie Coupar; Paul E Clavijo; Anthony Saleh; Tsu-Fan Cheng; Xinping Yang; Jianhong Chen; Carter Van Waes; Zhong Chen
Journal:  Mol Carcinog       Date:  2018-11-28       Impact factor: 4.784

Review 5.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

6.  Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.

Authors:  Xinping Yang; Hui Cheng; Jianhong Chen; Ru Wang; Anthony Saleh; Han Si; Steven Lee; Emine Guven-Maiorov; Ozlem Keskin; Attila Gursoy; Ruth Nussinov; Jugao Fang; Carter Van Waes; Zhong Chen
Journal:  Cancer Immunol Res       Date:  2019-10-17       Impact factor: 11.151

Review 7.  Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?

Authors:  Amit Dipak Amin; Tara L Peters; Lingxiao Li; Soumya Sundara Rajan; Ramesh Choudhari; Soham D Puvvada; Jonathan H Schatz
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-05

8.  The association of lymphotoxin-beta receptor with the subsequent diagnosis of incident gastrointestinal cancer: results from the Dallas Heart Study.

Authors:  Colin P Bergstrom; Muhammad S Beg; Colby Ayers; Arjun Gupta; Ian J Neeland
Journal:  J Gastrointest Oncol       Date:  2020-02

Review 9.  Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues.

Authors:  Theresa T Lu; Jeffrey L Browning
Journal:  Front Immunol       Date:  2014-02-11       Impact factor: 7.561

10.  Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases.

Authors:  Nora Rippaus; David Taggart; Jennifer Williams; Tereza Andreou; Heiko Wurdak; Krzysztof Wronski; Mihaela Lorger
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.